We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Training Device Improves Accuracy of Pooled Molecular Diagnostics

By LabMedica International staff writers
Posted on 09 Jul 2026

High-throughput molecular diagnostics have transformed infectious disease detection, but many workflows remain difficult to execute accurately without extensive training. More...

Sample pooling can cut per‑test costs and raise throughput, yet it is prone to transfer errors, cross‑contamination, and documentation lapses that compromise results. At the same time, shortages of trained personnel limit access to advanced testing in decentralized and mobile settings. A new study describes an interactive device that helps novices perform pooled nucleic acid amplification tests (NAATs) with high accuracy.

In work published in PNAS Nexus, researchers developed a “train‑and‑assist” device designed to upskill laboratory‑inexperienced users for sample pooling workflows. The system monitors a user’s progress through each step of pooling equal volumes from multiple specimens for NAATs that detect diverse infectious pathogens. It is presented as a way to expand reliable pooling beyond settings that have automated liquid handlers or specialized staff.

The device provides step‑by‑step guidance, tracks progress, and weighs each sample tube precisely to verify transfers. It delivers real‑time feedback when too much or too little sample is added and helps users correct mistakes that are still fixable. When an error is deemed uncorrectable, the system instructs the user to terminate the process. Built for broad accessibility, the apparatus uses low‑cost, off‑the‑shelf electronics, 3D‑printed modules, and open‑source systems, with a total estimated cost of about $600 per unit.

Performance was evaluated in a study of 48 participants, 37 of whom had little or no previous laboratory experience. Compared with paper instructions, the device enabled users to pool mock clinical samples with high accuracy, reduced uncorrected handling errors, improved volume‑transfer technique, and produced high‑quality pools. The authors indicate these gains were achieved while guiding novices through a standard pooling protocol.

According to the authors, such tools could make pooled NAATs logistically and financially feasible for large‑scale surveillance programs, including those that must estimate low disease prevalence and inform decisions about when mass drug administration can be stopped. The study was published in PNAS Nexus on July 7, 2026, under the title “A train‑and‑assist device that upskills novices to strengthen the workforce and expand diagnostic access.”


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: A new AI assistant supports treatment decisions in complex blood cancers (Image Credit: Shutterstock)

AI Decision Support System Guides Treatment Selection for Complex Blood Cancers

Treatment selection for hematologic malignancies often requires clinicians to synthesize clinical histories, genomic alterations, prior therapies, and rapidly evolving drug options. These complex decisions... Read more

Immunology

view channel
Image

Anti-Lipid Antibody Biomarkers May Identify Early Lyme Disease and Persistent Symptoms

Lyme disease is often missed during its earliest and most treatable stage, while current serologic assays cannot distinguish active infection from prior exposure. Nearly half a million Americans are diagnosed... Read more

Industry

view channel
Im

Eurobio Scientific Completes Acquisition of CareDx Lab Products Division

Eurobio Scientific has closed the acquisition of CareDx AB in Sweden and its fully owned subsidiaries in the United States and Australia that constitute CareDx’s Lab Products division. The business will... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.